Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ackermans & van Haaren NV | ACKB | Apr 25, 2025 | 211.00 | +0.67 |
Aedifica SA | AED | Apr 25, 2025 | 67.75 | +0.52 |
Ageas | AGS | Apr 25, 2025 | 53.70 | -0.09 |
Agfa-Gevaert NV | AGFB | Apr 25, 2025 | 0.90 | -1.86 |
AHOLD DEL | AD | Apr 25, 2025 | 35.70 | -0.56 |
APERAM | APAM | Apr 25, 2025 | 27.32 | +1.34 |
Argen X SE | ARGX | Apr 25, 2025 | 535.80 | +0.79 |
Ascencio Sca | ASCE | Apr 25, 2025 | 46.60 | +0.43 |
Atenor | ATEB | Apr 25, 2025 | 2.90 | -1.69 |
AVANTIUM | AVTX | Apr 25, 2025 | 0.77 | +2.67 |
Azelis Group NV | AZE | Apr 25, 2025 | 13.61 | +3.42 |
Banco Bilbao Vizcaya Argentaria SA | BBV | Apr 25, 2025 | 7.80 | 0.00 |
Banco Santander SA | SANTA | Apr 25, 2025 | 3.58 | 0.00 |
Banimmo SA | BANI | Apr 25, 2025 | 2.92 | +1.37 |
Banque Nationale de Belgique | BNB | Apr 25, 2025 | 345.00 | +5.18 |
Barco NV | BAR | Apr 25, 2025 | 11.95 | -0.17 |
Basilix | BAS | Apr 25, 2025 | 27.80 | 0.00 |
Beaulieu Av Certificates | BEAB | Apr 25, 2025 | 1.19 | 0.00 |
Befimmo SA | BEFB | Apr 25, 2025 | 46.10 | 0.00 |
Bel20 | BEL20 | Apr 25, 2025 | 4 306.05 | +0.37 |
Belreca - Belgian Resources and Capital Company | BELR | Apr 25, 2025 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 25, 2025 | 0.32 | 0.00 |
Belysse Group N.V. | BELYS | Apr 25, 2025 | 0.79 | +1.95 |
Biocartis Group NV | BCART | Apr 25, 2025 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 25, 2025 | 0.00 | 0.00 |
Biotalys | BTLS | Apr 25, 2025 | 3.17 | -0.31 |
Boeing | BOEI | Apr 25, 2025 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 25, 2025 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 25, 2025 | 1.42 | -3.13 |
Brederode S.A. | BREB | Apr 25, 2025 | 110.90 | +0.42 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.